Skip to main content

Table 3 Comparing health-related quality of life domains scoring between study groups

From: Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy

QLQ-PR25

Variables

Prostate RT group

Control group

P-value

Mean (SD)

Mean (SD)

QoL Urinary functions

 

Baseline

78.19 (15.11)

77.44 (14.58)

0.844

3 months

18.75 (20.25)

62.19 (15.67)

< 0.001*

6 months

15.19 (17.33)

59.24 (18.20)

< 0.001*

9 months

12.5 (14.96)

61.04 (20.56)

< 0.001*

12 months

11.22 (15.17)

59.29 (22.89)

< 0.001*

QoL Bowel functioning

 

Baseline

15.44 (11.26)

8.33 (8.34)

0.707

3 months

12.5 (9.7)

13.58 (14.83)

0.738

6 months

11.02 (8.97)

11.96 (13.02)

0.756

9 months

8.63 (5.78)

13.33 (13.63)

0.108

12 months

15.38 (20.93)

14.08 (17.12)

0.114

QoL Incontinence aid

 

Baseline

16.67 (83.34)

31.03 (44.48)

0.147

3 months

13.54 (30.36)

25.93 (38.49)

0.173

6 months

11.83 (29.25)

20.29 (31.37)

0.313

9 months

10.71 (28.77)

21.67 (34.67)

0.239

12 months

11.54 (29.73)

28.21 (38.12)

0.142

QoL ADT symptoms

 

Baseline

58.33 (16.08)

68.01 (10.46)

0.006*

3 months

62.33 (17.04)

75.72 (6.19)

< 0.001*

6 months

64.87 (17.36)

77.05 (4.53)

< 0.001*

9 months

65.87 (18.31)

78.61 (4.52)

0.001*

12 months

64.96 (18.51)

79.06 (5.15)

0.001*

QoL Sexual activity

 

Baseline

28.92 (18.03)

12.64 (12.32)

< 0.001*

3 months

16.40 (13.96)

9.88 (11.56)

0.058

6 months

14.78 (13.56)

8.7 (12.17)

0.095

9 months

13.1 (10.5)

6.67 (11.34)

0.053

12 months

13.46 (10.56)

7.69 (11)

0.121

QoL Sexual functioning

 

Baseline

12.26 (11.83)

2.3 (5.41)

< 0.001*

3 months

2.86 (5.44)

2.47 (4.51)

0.765

6 months

2.96 (5.51)

1.89 (3.57)

0.431

9 months

3.27 (5.71)

0.83 (2.56)

0.081

12 months

3.53 (5.86)

0.64 (2.31)

0.097

  1. *. Statistically significant p value derived from independent samples t-test, SD: standard deviation.
  2. QoL: quality of life, RT: radiotherapy, QLQ: quality of life questionnaire, ADT: Androgen deprivation therapy.